Patent Issued for Sensor device for detecting at least one analyte in a body fluid of a user (USPTO 12042274).

Roche Diabetes Care Inc. has been issued a patent for a sensor device that can detect analytes in a user's body fluid, such as blood glucose levels. The device is designed for continuous monitoring and can be used in both home care and professional care settings. The sensor is applied under the skin, while the control part of the system is located outside the body. The patent describes various features and methods to ensure accurate measurements and protect the sensor from humidity and other substances. It also includes an evaluation device that compares the analyte concentration with threshold values and prepares a warning signal if the concentration exceeds the first threshold value. The device can communicate with a medication device to determine the dosage of insulin delivered to the user. The evaluation device can adjust the tolerance time interval and offset time interval based on user preferences or events that affect the analyte concentration. The patent was filed by Christian Ringemann and published in 2024. [Extracted from the article]